Pharmaceuticals

Biopharmaceutical expansion is fueling growth in the Phosphoramidite Market 2026

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Phosphoramidite Market Over The 2026–2030 Period?

The phosphoramidite market has experienced robust expansion over the past few years. It is projected to expand from $1.07 billion in 2025 to $1.15 billion by 2026, registering a compound annual growth rate (CAGR) of 7.1%. Historically, this growth can be attributed to an increase in DNA sequencing activities, the expansion of academic research funding, a greater use of synthetic nucleic acids, the development of solid-phase synthesis techniques, and rising demand for molecular diagnostics.

The phosphoramidite market size is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. Key drivers for this growth during the projection period include the broadening scope of RNA-based therapeutics, advancements in gene editing technologies, heightened investment in pharmaceutical research and development, an increasing need for custom oligonucleotides, and the expansion of automated synthesis platforms. Significant trends identified for the forecast timeframe encompass an escalating requirement for oligonucleotide synthesis materials, the enlargement of gene therapy and RNA therapeutics applications, wider incorporation into diagnostic and research uses, increasing integration of automated solid-phase synthesis methods, and a sharpened emphasis on chemical inputs of high purity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Underlying Factors Are Accelerating The Growth Of The Phosphoramidite Market?

The expanding biopharmaceutical sector is anticipated to drive the future growth of the phosphoramidite market. This sector refers to the industry engaged in the research, development, production, and commercialization of biologically derived medical products, encompassing vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is a result of advancements in biotechnology, the increasing prevalence of chronic diseases, and greater investments in research and development. Biotechnology innovations, such as gene editing and monoclonal antibody therapies, have led to more effective and targeted treatments. For instance, in October 2025, the Office for National statistics, a UK-based government department, reported that in 2024, the UK life sciences industry consisted of 6,170 businesses operating across 7,320 sites, employing 359,600 people, and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest by both company count and workforce, accounting for 60% of all companies and 55% of total employment. Thus, the growth of the phosphoramidite market is being propelled by the expansion of the biopharmaceutical sector.

How Is The Phosphoramidite Market Segmented Across Key Categories?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

Which Upcoming Trends Are Expected To Influence The Phosphoramidite Market?

Leading entities within the phosphoramidite market are prioritizing the creation of advanced DNA synthesis methods, such as convertible-preferred stock financing rounds, to boost the implementation and advancement of Gibson SOLA technology for quick DNA and mRNA synthesis. This type of financing involves a company securing funds by issuing preferred shares, which possess the option to be converted into a set quantity of common shares at a future date. An illustrative example is from March 2025, when Telesis Bio Inc., a biotechnology firm based in the US, disclosed it had obtained new funding totaling up to $21 million. This capital injection is intended to hasten the market introduction of its innovative enzymatic DNA synthesis platform, Gibson SOLA, backed by various strategic investors. The purpose of these funds is to scale up the company’s entirely enzymatic DNA synthesis technology, expand its research and development as well as manufacturing capacities, and increase availability for fast, customizable production of long DNA. The firm employs a unique enzymatic strategy that facilitates the swift and accurate synthesis of extended DNA sequences, thereby resolving existing limitations linked to conventional phosphoramidite-based techniques.

Who Are The Dominant Players Shaping The Phosphoramidite Market Landscape?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Read the full phosphoramidite market report here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Projected To Dominate The Phosphoramidite Market During The Forecast Period?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Phosphoramidite Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795